Philips and Chinese Institute of Health Sciences join forces in
molecular medicine
12 September 2007 Shanghai, China. Royal Philips Electronics and the
Chinese Institute of Health Sciences (IHS) have announced an agreement to
establish a joint research laboratory within the IHS in Shanghai. The joint
laboratory will conduct advanced research in the field of molecular
medicine. The ultimate aim is to create new solutions for the early
diagnosis of disease and for monitoring the effectiveness of subsequent
treatment. Early diagnosis and personalized treatment will lead to increased
comfort and better outcomes for patients. As part of this unique
collaboration, Philips intends to locate a team of its own scientists at the
joint research laboratory. “This agreement to set up a joint research
laboratory with the IHS in China is a prime example of the Open Innovation
approach that Philips is taking in order to bring the many benefits of
molecular medicine into patient care.” says Rick Harwig, CTO of Royal
Philips Electronics.
The IHS is part of the Shanghai Institutes for Biological Sciences (SIBS)
and is also affiliated to the Shanghai Jiao Tong University School of
Medicine.
“This collaboration will give us access to Philips’ global research
organization, especially the European laboratories, and should serve as a
good example for further European collaborations,” said Professor Rongxing
Gan, Vice President of SIBS. “The combination of our expertise in
translational biomedical research and Philips’ expertise in advanced medical
instrumentation will definitely accelerate the development of new healthcare
solutions for the Chinese people as well as people around the world.”
To top
Save this page on del.icio.us
|